HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy.

AbstractOBJECTIVES:
The aims of this study were: 1) to investigate forkhead box P3 (FOXP3) expression in patients with Kawasaki disease (KD), exploring possible differences during the acute phase and after defervescence; 2) to evaluate a possible association of the FOXP3 single nucleotide polymorphism (SNP) 543 (SNP ID: rs2232367) with KD.
METHODS:
FOXP3 expression was evaluated on 8 children with KD and 15 healthy children by flow cytometry and Real-Time polymerase chain reaction (RT-PCR). FOXP3 SNP 543 was genotyped by denaturing high-performance liquid chromatography (DHPLC) and sequencing on DNA samples from 58 additional children with KD and 114 healthy donors.
RESULTS:
The frequencies of CD4+CD25 +FOXP3+ regulatory T cells were significantly (p=0.0002) lower during the acute phase of KD than in sex- and age-matched healthy donors (median % + SD: 4.8+/-1.3 vs. 7.7+/-1.7) and a similar tendency was revealed for FOXP3 mRNA transcripts (p<0.0001). FOXP3 expression increased significantly, at both protein and mRNA levels, after intravenous immunoglobulin (IVIG) therapy treatment and achieving complete remission of disease (at least 48 hrs; median 9.5 days, range 2-30). Of the 58 patients screened, only one female subject (1.7%) carried the presence of 543 SNP in heterozygosis (C>T; for a total of 1 allele out of 88), with no difference between KD patients and controls (0.0%, 0/203 alleles).
CONCLUSIONS:
Our data reinforce the notion of an impaired immunoregulation in KD, suggesting also a role of IVIG treatment in modifying the Treg compartment. FOXP3 SNP 543 does not seem to be involved in susceptibility to KD in Italian children.
AuthorsBiagio Olivito, Andrea Taddio, Gabriele Simonini, Cristina Massai, Sara Ciullini, Eleonora Gambineri, Maurizio de Martino, Chiara Azzari, Rolando Cimaz
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2010 Jan-Feb Vol. 28 Issue 1 Suppl 57 Pg. 93-7 ISSN: 0392-856X [Print] Italy
PMID20412712 (Publication Type: Journal Article)
Chemical References
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Immunoglobulins, Intravenous
  • RNA, Messenger
Topics
  • Acute Disease
  • Child
  • Child, Preschool
  • Female
  • Flow Cytometry
  • Forkhead Transcription Factors (genetics, metabolism)
  • Genotype
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage)
  • Infant
  • Italy
  • Male
  • Mucocutaneous Lymph Node Syndrome (genetics, immunology, therapy)
  • Polymorphism, Single Nucleotide
  • RNA, Messenger (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • T-Lymphocytes, Regulatory (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: